Table 1.
Drug | Neuropathic-pain conditions | |||||
---|---|---|---|---|---|---|
| ||||||
PLP | PPN | PHN | TN | HIV | CP | |
Acetaminophen | CrS/P | |||||
NSAIDs | CrS/P | |||||
Antidepressants tricyclics | ||||||
Amitriptyline | CT/P/N | CT/Pb | CT/Pb | CT/N | CTb | |
Desipramine | CT/Pb | CT/Pb | b | |||
Imipramine | CT/Pb, | CT/Pb | b | |||
Nortriptyline | CT/Pb | CT/Pb | b | |||
Clomipramine | CT/Pb | CT/Pb | ||||
Trazadone | CT/P | |||||
Maprotiline | CT/Pb | CT/Pb | b | |||
Tetracyclics | ||||||
Mirtazapine | CS | |||||
SSRIs | ||||||
Escitalopram | CT/P | |||||
Fluoxetine | CT/P | |||||
Paroxetine | CT/P | |||||
Sertraline | OLT/P | |||||
Bupropion | CT/P | CT/P | ||||
SNRIs | ||||||
Duloxetine | CR | CT/Pb | ||||
Venlafaxine ER | CT/N | CT/Pb | CT/P | |||
Milnacipran | CR | |||||
Anticonvulsants calcium channel alpha 2 delta ligands | ||||||
Gabapentin | CT/P | CT/P/Nb | CT/Pb | CR | CT/N | CT/Pb |
Pregabalin | CT/P | CT/Pb | CT/P | CT/N | CT/Pb | |
Carbamazepine | CT/P | CT/Pb | ||||
Lamotrigine | CT/P/N | CT/P/N | ||||
Oxcarbamazepine | CT/Pb | |||||
Phenytoin | CT/P/N | |||||
Topiramate | CT/P/N | |||||
Valproate | CT/P/N | CT/P | CT/N | |||
Sodium channel blockers | ||||||
Bupivacaine (inject) | CT/P | |||||
Lidocaine | ||||||
Infusion | CT/N | CT/P | ||||
Patches | CT/P | |||||
Mexiletine | CT/P/N | CT/N | CT/N | |||
NMDA receptor antagonists | ||||||
Memantine | CR/P/N | CT/P/N | CT/N | |||
Ketaminec | CT/N | |||||
Dextromethorphan | CT/P | CT/N | ||||
NMDA+Potassium channel blocker | CR | |||||
Flupirtine (plus opioids) | ||||||
Opioids | ||||||
Morphine | CT/P | CT/P | CT/P | |||
Methadone | CS | |||||
Buprenorphined | CR/P | |||||
Oxycodone | CR/P | CT/P | CT/P | |||
Levorphanol | CT(M) | |||||
Tramadol | CT/P | CT/P | CT/P | |||
Muscle relaxants | ||||||
Baclofen | CRd | CT/P | ||||
Benzodiazepines | ||||||
Clonazepam | CS | |||||
Diazepam | CT/P | |||||
Alprazolam | OLT | |||||
Corticosteroids | ||||||
Prednisone | CS | |||||
Dexamethasone | CS | |||||
Capsaicin | CT/P/N | CT/P | CT/N |
Notes: In bold characters, reports and studies specifically designed to test drugs on PLP.
Only highest level of evidence for each drug and condition reported;
first-line drugs according to EFNS guidelines;
intravenous infusion;
intrathecal analgesia.
Abbreviations: CrS, cross-sectional study; CR, case report/case series; CT, controlled trial; OLT, open label trial; M, mixed patient population; P, positive clinical trial; N, negative clinical trial; P/N, mixed clinical trial results; PLP, phantom limb pain; PPN, painful polyneuropathy; PHN, post-herpetic neuralgia; TN, trigeminal neuralgia; CP, central pain (post-stoke and spinal cord injury); NSAIDs, nonsteroidal anti-inflammatory drugs; SSRIs, selective serotonin reuptake inhibitors; SNRIs, serotoninnorepinephrine reuptake inhibitors; NMDA, N-Methyl-D-Aspartate.